Sodium Glucose Cotransporter 2 Inhibitors and Amputation Risk
Author:
Affiliation:
1. TIMI Study Group, Brigham and Women’s Hospital Heart and Vascular Center, Boston, MA (M.P.B.)
2. Cardiovascular Division, Vanderbilt University, Nashville, TN (J.A.B.)
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Link
https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.118.032745
Reference14 articles.
1. Vascular Complications of Diabetes
2. Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
3. Empagliflozin and Assessment of Lower-Limb Amputations in the EMPA-REG OUTCOME Trial
4. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
5. Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Amputation Risk in Type II Diabetes Mellitus Patients Treated with SGLT-2 Inhibitors: A Systematic Literature Review of Randomized Clinical Trials;Drug Research;2024-08-02
2. Risk of major adverse limb events in patients with type 2 diabetes mellitus receiving sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based retrospective cohort study;Frontiers in Pharmacology;2022-09-13
3. Prevention of Peripheral Arterial Disease;Contemporary Cardiology;2020-12-22
4. Management of Diabetes Mellitus in Acute and Chronic Cardiorenal Syndromes;Textbook of Cardiorenal Medicine;2020-11-25
5. Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58;Circulation;2020-08-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3